Bank of New York Mellon’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $754K | Buy |
202,214
+15,301
| +8% | +$57.1K | ﹤0.01% | 3262 |
|
|
2025
Q1 | $516K | Buy |
186,913
+605
| +0.3% | +$1.67K | ﹤0.01% | 3399 |
|
|
2024
Q4 | $1.03M | Buy |
186,308
+24,930
| +15% | +$138K | ﹤0.01% | 3127 |
|
|
2024
Q3 | $1.35M | Sell |
161,378
-15,295
| -9% | -$128K | ﹤0.01% | 2965 |
|
|
2024
Q2 | $1.2M | Buy |
176,673
+64,018
| +57% | +$436K | ﹤0.01% | 3084 |
|
|
2024
Q1 | $739K | Sell |
112,655
-7,430
| -6% | -$48.7K | ﹤0.01% | 3305 |
|
|
2023
Q4 | $779K | Sell |
120,085
-8,939
| -7% | -$58K | ﹤0.01% | 3317 |
|
|
2023
Q3 | $649K | Buy |
129,024
+646
| +0.5% | +$3.25K | ﹤0.01% | 3408 |
|
|
2023
Q2 | $1.12M | Buy |
128,378
+107,990
| +530% | +$945K | ﹤0.01% | 3124 |
|
|
2023
Q1 | $241K | Buy |
+20,388
| New | +$241K | ﹤0.01% | 3844 |
|
|
2022
Q2 | – | Sell |
-38,059
| Closed | -$112K | – | 4693 |
|
|
2022
Q1 | $112K | Buy |
38,059
+2,359
| +7% | +$6.94K | ﹤0.01% | 4384 |
|
|
2021
Q4 | $253K | Buy |
35,700
+8,187
| +30% | +$58K | ﹤0.01% | 4166 |
|
|
2021
Q3 | $287K | Buy |
27,513
+4,227
| +18% | +$44.1K | ﹤0.01% | 4055 |
|
|
2021
Q2 | $286K | Buy |
23,286
+4,007
| +21% | +$49.2K | ﹤0.01% | 3979 |
|
|
2021
Q1 | $424K | Buy |
+19,279
| New | +$424K | ﹤0.01% | 3775 |
|